Contents

Research into molecular medicine is discovering natural treatments for many health disorders including schizophrenia.  Our understanding of nutrient-based treatment options in schizophrenia is growing quickly.

SchizophreniaOptions is dedicated to raising awareness of new treatments and natural treatments in schizophrenia. While there is a specific focus on Negative and Cognitive Symptoms, other issues are discussed as well.

This site started as a location for an archived presentation given to the National Alliance for Mental Illness (NAMI-LA) in May 2012.  It provides greater explanation of the importance of supporting NMDA receptor function in schizophrenia, as well as details regarding the research outcomes with NAC and Sarcosine in published studies.

ProFrontal is currently the most specific source for Sarcosine available in the U.S.

Sarcosine

The only Glycine Transporter Type 1 Inhibitor currently available.

Sarcosine is a natural molecule in human metabolism that has research supporting use in schizophrenia.

N-Acetyl Cysteine (NAC)

NAC is an antioxidant and a precursor to Glutathione, a natural and essential antioxidant that is severely depleted in schizophrenia.

Methyl-Folate and B12

Folate and B12 cycling and methylation donation processes are often severely impacted in schizophrenia for various reasons.  Supplementation may correct some of these common deficiencies and improve symptoms.

Celecoxib

Celecoxib is a prescription medication that inhibits the Cycloxygenase-2 (COX-2), an enzyme that increases inflammation.  Research evidence has shown that early treatment with celecoxib may improve symptoms in the early stages of schizophrenia.

Archived Talks

PART 1:     New Options in the Treatment of Negative and Cognitive Symptoms in Schizophrenia.  Jeffrey Becker, MD, Private Practice Psychiatrist and UCLA/NPI Volunteer Clinical Faculty.  May 2012 – NAMI Los Angeles

PART 2:     New Options in the Treatment of Negative and Cognitive Symptoms in Schizophrenia.  Jeffrey Becker, MD, Private Practice Psychiatrist and UCLA/NPI Volunteer Clinical Faculty.  May 2012 – NAMI Los Angeles

The NMDA Receptor, Glutamate and Glycine

A discussion of NMDA Receptor physiology and importance in schizophrenia, as well as an explanation of Glutamate and Glycine, its dual activating neurotransmitters.

Negative and Cognitive Symptoms of Schizophrenia

What are the negative and cognitive symptoms and how do they differ from the Positive symptoms of the disorder?  How can these different symptoms be targeted in research and treatment of schizophrenia?

Links

A list of helpful resources for individuals and families seeking comprehensive treatment for schizophrenia.

You must log in to post a comment.